loading page

PREDICTORS OF MORTALITY IN CHILDREN WITH CYSTIC FIBROSIS
  • +2
  • Hardeep Kaur,
  • Shivam Pandey,
  • Kana Jat,
  • RAKESH LODHA,
  • Sushil Kabra
Hardeep Kaur
All India Institute of Medical Sciences

Corresponding Author:[email protected]

Author Profile
Shivam Pandey
All India Institute of Medical Sciences
Author Profile
Kana Jat
All India Institute of Medical Sciences
Author Profile
RAKESH LODHA
AIIMS
Author Profile
Sushil Kabra
All India Institute of Medical Sciences
Author Profile

Abstract

Background: There is a lack of studies on outcomes in cystic fibrosis (CF) in children from developing countries like India. Identifying risk factors for mortality may help identify the high-risk group and plan policy management of such patients. Objective: To determine the factors associated with outcomes among Indian children with CF. Design: Retrospective analysis of data collected from January 2010 to Dec 2020. Setting: Tertiary care hospital in Northern India. Participants: Children diagnosed with CF during the study period. Methods: We extracted data related to demography, clinical features, laboratory data and outcome from children’s medical records with CF. Bivariate and multivariate analysis was performed to identify variables associated with mortality. Results: We enrolled 178 children, and there were 32 (18.0%) deaths. Significant factors associated with mortality included history of neonatal complications; hazard ratio (HR): 8.5 (95% CI, 3.0 - 23.9, p < 0.001), low Z-scores for body mass index (BMI) at the time of diagnosis; HR: 7.1 (95% CI 2.3 - 22.0, p < 0.001), FEV1/FVC at the time of diagnosis; HR: 5.1 (95% CI, 1.65 - 15.4, p-value < 0.004), and FEV1 25-75; HR: 3.6 (95% CI, 1.1- 11.8, p-value = 0.03). Conclusions: Factors associated with increased risk of mortality included presence of neonatal complications, low BMI and lower pulmonary function test results. Low BMI and low PFT indices are modifiable and possibly can be improved by early diagnosis. A new-born screening test may help in early diagnosis and identification of the neonatal problem of CF.
07 Jun 2021Submitted to Pediatric Pulmonology
18 Jun 2021Submission Checks Completed
18 Jun 2021Assigned to Editor
20 Jun 2021Reviewer(s) Assigned
02 Jul 2021Review(s) Completed, Editorial Evaluation Pending
08 Jul 2021Editorial Decision: Revise Major
15 Sep 20211st Revision Received
16 Sep 2021Submission Checks Completed
16 Sep 2021Assigned to Editor
16 Sep 2021Reviewer(s) Assigned
28 Sep 2021Review(s) Completed, Editorial Evaluation Pending
29 Sep 2021Editorial Decision: Revise Minor
07 Oct 20212nd Revision Received
08 Oct 2021Submission Checks Completed
08 Oct 2021Assigned to Editor
08 Oct 2021Reviewer(s) Assigned
10 Oct 2021Review(s) Completed, Editorial Evaluation Pending
10 Oct 2021Editorial Decision: Revise Minor
11 Oct 20213rd Revision Received
12 Oct 2021Submission Checks Completed
12 Oct 2021Assigned to Editor
12 Oct 2021Review(s) Completed, Editorial Evaluation Pending
12 Oct 2021Editorial Decision: Accept